PFE vs SNDK: Which Is the Better Buy?

Side-by-side comparison of Pfizer Inc. and Sandisk Corporation โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-18.
Pfizer Inc. ยท Healthcare
$27.64
+12.0% upside to fair value
Med Conviction Grade B
VS
Sandisk Corporation ยท Technology
$1,614.39
-25.3% upside to fair value
Med Conviction Grade C
QuantHub Verdict
PFE has more upside to fair value (+12.0%). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric PFE SNDK
Current Price $27.64 $1,614.39
Fair Value Estimate $30.94 $1,206.72
Upside to Fair Value +12.0% -25.3%
Market Cap $157.5B $239.1B
Forward P/E โ€” โ€”
EV / EBITDA 17.4x 17.9x
Price / Sales 2.5x 11.8x
Price / FCF 14.3x 20.6x
Revenue Growth YoY +2.6% +371.6%
Gross Margin 71.3% 71.5%
Operating Margin 25.1% 61.2%
Return on Equity 4.9% 93.1%
Dividend Yield 6.22% 0%
FCF Yield 6.97% 4.84%
Analyst Consensus Hold Strong Buy
Investment Thesis
PFE โ€” Pfizer Inc.
Pfizer is a global biopharmaceutical leader with a portfolio spanning cardiovascular, oncology, vaccines, immunology, and rare disease, anchored by Eliquis, the Prevnar family, Vyndaqel, Ibrance, Xtandi, Comirnaty, and Paxlovid, and supported by roughly 75,000 employees and a contract manufacturing division. Business quality is medium rather than high: TTM gross margin of 71.3% and TTM operating โ€ฆ
SNDK โ€” Sandisk Corporation
Sandisk designs and manufactures NAND flash storage solutions, including SSDs, embedded memory, removable cards, USB devices, and wafers, employing roughly 11,100 people from its Milpitas, California headquarters. The business is currently generating extraordinary profitability, with TTM gross margin of 71.5%, operating margin of 61.2%, net margin of 56.5%, and ROE of 93.1%, while revenue grew 37โ€ฆ
Accumulation Zones
Metric PFE SNDK
Zone Low $23.21 $905.04
Zone High $26.30 $1,025.71
In Buy Zone? No No
โ† PFE Research    SNDK Research โ†’    All Research